Using pyrene-labeled HIV-1 TAR to measure RNA - Small molecule binding

Nucleic Acids Research

Volumn 31, Issue 19, 2003, Pages 5490-5500

  Blount, Kenneth F ^a   Tor, Yitzhak ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; KANAMYCIN A; KANAMYCIN B; LIGAND; NEOMYCIN; NUCLEIC ACID; PAROMOMYCIN; PYRENE; RIBOSTAMYCIN; TOBRAMYCIN; VIRUS RNA; AMINOGLYCOSIDE; FLUORESCENT DYE; FRAMYCETIN; PYRENE DERIVATIVE; RIBONUCLEASE; RIBONUCLEASE V(1); RNA;

ARTICLE; BINDING AFFINITY; BINDING ASSAY; CONTROLLED STUDY; DERIVATIZATION; DRUG BINDING; DRUG SELECTIVITY; DRUG SPECIFICITY; ELECTRICITY; ENERGY; FLUORESCENCE ANALYSIS; GENE TARGETING; GENETIC MODEL; HUMAN IMMUNODEFICIENCY VIRUS 1; IONIC STRENGTH; ISOTHERM; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; RNA BINDING; TRANSACTIVATION; VIRUS TITRATION; BINDING COMPETITION; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; EVALUATION; GENETICS; LONG TERMINAL REPEAT; METABOLISM; NUCLEOTIDE SEQUENCE; OSMOLARITY; SPECTROFLUOROMETRY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

AMINOGLYCOSIDES; BASE SEQUENCE; BINDING SITES; BINDING, COMPETITIVE; ELECTROSTATICS; ENDORIBONUCLEASES; FLUORESCENT DYES; FRAMYCETIN; HIV LONG TERMINAL REPEAT; HIV-1; MODELS, MOLECULAR; NEOMYCIN; NUCLEIC ACID CONFORMATION; OSMOLAR CONCENTRATION; PYRENES; RNA; SPECTROMETRY, FLUORESCENCE;

EID: 0141905902     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkg755     Document Type: Article

References (53)

1. Hermann,T. and Westhof,E. (1998) RNA as a drug target: chemical, modeling and evolutionary tools. Curr. Opin. Biotechnol., 9, 66-73.
2. Hermann,T. (2000) Strategies for the design of drugs targeting RNA and RNA-protein complexes. Int. Ed. Engl., 39, 1891-1905.
3. Davies,J., Gorini,L. and Davis,B.D. (1965) Misreading of RNA code words induced by aminoglycoside antibiotics. Mol. Pharmacol., 1, 93-106.
4. Moazed,D. and Noller,H.F. (1987) Interactions of antibiotics with functional sites in 16S ribosomal RNA. Nature, 327, 389-394.
5. Woodcock,J., Moazed,D., Cannon,M., Davies,J. and Noller,H.F. (1991) Interaction of antibiotics with A- and P-site-specific bases in 16S ribosomal RNA. EMBO J., 10, 3099-3103.
6. Kirk,S.R. and Tor,Y. (1999) tRNA(Phe) binds aminoglycoside antibiotics. Bioorg. Med. Chem., 7, 1979-1991.
7. Stage,T.K., Hertel,K.J. and Uhlenbeck,O.C. (1995) Inhibition of the hammerhead ribozyme by neomycin. RNA, 1, 95-101.
8. Earnshaw,D.J. and Gait,M.J. (1998) Hairpin ribozyme cleavage catalyzed by aminoglycoside antibiotics and the polyamine spermine in the absence of metal ions. Nucleic Acids Res., 26, 5551-5561.
9. von Ahsen,U., Davies,J. and Schroeder,R. (1991) Antibiotic inhibition of group I ribozyme function. Nature, 353, 368-370.
10. Zapp,M.L., Stem,S. and Green,M.R. (1993) Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production. Cell, 74, 969-978.
11. Mei,H.Y., Mack,D.P., Galan,A.A., Halim,N.S., Heldsinger,A., Loo,J.A., Moreland,D.W., Sannes-Lowery,K.A., Sharmeen,L., Truong,H.N. et al. (1997) Discovery of selective, small-molecule inhibitors of RNA complexes-I. The Tat protein/TAR RNA complexes required for HIV-1 transcription. Bioorg. Med. Chem., 5, 1173-1184.
12. Ennifar,E., Paillart,J.C., Marquet,R., Ehresmann,B., Ehresmann,C., Dumas,P. and Walter,P. (2003) HIV-1 RNA dimerization initiation site is structurally similar to the ribosomal A-site and binds aminoglycoside antibiotics. J. Biol. Chem., 278, 2723-2730.
13. Frankel,A.D. (1992) Activation of HIV transcription by Tat. Curr. Opin. Gen. Devo., 2, 293-298.
14. Jones,K.A. and Peterlin,B.M. (1994) Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem., 63, 717-743.
15. Karn,J., Keen,N.J., Churcher,M.J., Aboul-ela,F., Varani,G., Hamy,F., Felder,E.R., Heizmann,G. and Kimkait,T. (1998) The HIV Tat-TAR interaction, a novel target for drug discovery. In Van der Goot,H. (ed.), Pharmacochemistry Library. Elsevier Health Sciences, Netherlands, Vol. 29, pp. 121-132.
16. Froeyen,M. and Herdewijn,P. (2002) RNA as a target for drug design, the example of Tat-TAR interaction. Curr. Top. Med. Chem., 10, 1957-1961.
17. Wang,S., Huber,P.W., Cui,M., Czarnik,A.W. and Mei,H.Y. (1998) Binding of neomycin to the TAR element of HIV-1 RNA induces dissociation of Tat protein by an allosteric mechanism. Biochemistry, 37, 5549-5557.
18. Faber,C., Sticht,H., Schweimer,K. and Rosch,P. (2000) Structural rearrangements of HIV-1 Tat-responsive RNA upon binding of neomycin B. J. Biol. Chem., 275, 20660-20666.
19. Umezawa,H. and Kondo,S. (1975) Ion-exchange chromatography of aminoglycoside antibiotics. Methods Enzymol., 43, 263-278.
20. Michael,K., Wang,H. and Tor,Y. (1999) Enhanced RNA binding of dimerized aminoglycosides. Bioorg. Med. Chem., 7, 1361-1371.
21. Kierzek,R., Li,Y., Turner,D.H. and Bevilacqua,P.C. (1993) 5′-Amino pyrene provides a sensitive, nonperturbing fluorescent probe of RNA secondary and tertiary structure formation. J. Am. Chem. Soc., 115, 4985-4992.
22. Silverman,S.K., Deras,M.L., Woodson,S.A., Scaringe,S.A. and Cech,T.R. (2000) Multiple folding pathways for the P4-P6 RNA domain. Biochemistry, 39, 12103-12512.
23. Silverman,S.K. and Cech,T.R. (1999) RNA tertiary folding monitored by fluorescence of covalently attached pyrene. Biochemistry, 38, 14224-14237.
24. Conlan,L.H. and Dupureur,C.M. (2002) Multiple metal ions drive DNA association by PvuII endonuclease. Biochemistry, 41, 14848-14855.
25. Beebe,J.A. and Fierke,C.A. (1994) Relaxation Kinetics. Academic Press, New York, NY.
26. Baliga,R. and Crothers,D.M. (2000) On the kinetics of distamycin binding to its target sites on duplex DNA. Proc. Natl Acad. Sci. USA, 97, 7814-7818.
27. Alberty,R.A. and Hammes,G.G. (1958) Application of the theory of diffusion-controlled reactions to enzyme kinetics. J. Phys. Chem., 62, 154-159.
28. Edwards,T.E. and Sigurdsson,S.T. (2002) Electron paramagnetic resonance dynamic signatures of TAR RNA-small molecule complexes provide insight into RNA structure and recognition. Biochemistry, 41, 14843-14847.
29. White,J.S. and White,D.C. (1997) Source Book of Enzymes. CRC Press, Boca Raton, FL.
30. Aboul-ela,F., Karn,J. and Varani,G. (1996) Structure of the HIV-1 TAR RNA in the absence of ligands reveals a novel conformation of the trinucleotide bulge. Nucleic Acids Res., 24, 3974-3981.
31. Mikkelsen,N.E., Brannvall,M., Virtanen,A. and Kirsebom,L.A. (1999) Inhibition of RNase P RNA cleavage by aminoglycosides. Proc. Natl Acad. Sci. USA, 96, 6155-6160.
32. Hendrix,M., Priestley,E.S., Joyce,G.F. and Wong,C.-H. (1997) Direct observation of aminoglycoside-RNA interactions by surface plasmon resonance. J. Am. Chem. Soc., 119, 3641-3648.
33. Wong,C.H., Hendrix,M., Priestley,E.S. and Greenberg,W.A. (1998) Specificity of aminoglycoside antibiotics for the A-site of the decoding region of ribosomal RNA. Chem. Biol., 5, 397-406.
34. Pelta,J., Livolant,F. and Sikorav,J.-L. (1996) DNA aggregation induced by polyamines and cobalthexamine. J. Biol. Chem., 271, 5656-5662.
35. Luedtke,N.W. and Tor,Y. (2000) A novel solid-phase assembly for identifying potent and selective RNA ligands. Int. Ed. Engl., 39, 1788-1790.
36. Kirk,S.R., Luedtke,N.W. and Tor,Y. (2000) Neomycin-acridine conjugate: a potent inhibitor of Rev-RRE binding. J. Am. Chem. Soc., 122, 980-981.
37. Leclerc,F. and Cedergren,R. (1998) Modeling RNA-ligand interactions: the Rev-binding element RNA-aminoglycoside complex. J. Med. Chem., 41, 175-182.
38. Alberts,B. (1994) Molecular Biology of the Cell, 3rd Edn. Garland Publishing, New York, NY.
39. Netzel,T.L., Zhao,M., Nafisi,K., Headrick,J., Sigman,M.S. and Eaton,B.E. (1995) Photophysics of 2′-deoxyuridine (dU) nucleosides covalently substituted with either 1-pyrenyl or 1-pyrenoyl: observation of pyrene-to-nucleoside charge-transfer emission in 5-(1-Pyrenyl)-dU. J. Am. Chem. Soc., 117, 9119-9128.
40. Manoharan,M., Tivel,K.L., Zhao,M., Nafisi,K. and Netzel,T.L. (1995) Base-sequence dependence of emission lifetimes for D141018-30-6NA oligomers and duplexes covalently labeled with pyrene: relative electron-transfer quenching efficiencies of A, G, C and T nucleosides toward pyrene. J. Phys. Chem., 99, 17461-17472.
41. Hermann,T. and Westhof,E. (1999) Docking of cationic antibiotics to negatively charged pockets in RNA folds. J. Med. Chem., 42, 1250-1261.
42. Lohman,T.M., deHaseth,P.L. and Record,M.T.,Jr (1980) Pentalysine-deoxyribonucleic acid interaction: a model for the general effects of ion concentrations on the interactions of proteins with nucleic acids. Biochemistry, 19, 3522-3530.
43. Record,M.T.,Jr, Anderson,C.F. and Lohman,T.M. (1978) Thermodynamic analysis of ion effects on the binding and conformational equilibria of proteins and nucleic acids: the roles of ion association or release, screening and ion effects on water activity. Q. Rev. Biophys., 11, 103-178.
44. Jiang,L., Majumdar,W.H., Jaishree,T.J., Weijun,X. and Patel,D.J. (1999) Saccharide-RNA recognition in a complex formed between neomycin B and and RNA aptamer. Structure, 7, 817-827.
45. Kaul,M. and Pilch,D. (2002) Thermodynamics of aminoglycoside-rRNA recognition: the binding of neomycin-class aminoglycosides to the A site of 16S rRNA. Biochemistry, 41, 7695-7706.
46. Carey,J. and Uhlenbeck,O.C. (1983) Kinetic and thermodynamic characterization of the R17 coat protein-ribonucleic acid interaction. Biochemistry, 22, 2610-2615.
47. Tor,Y., Hermann,T. and Westhof,E. (1998) Deciphering RNA recognition: aminoglycoside binding to the hammerhead ribozyme. Chem. Biol., 5, R277-283.
48. Michael,K. and Tor,Y. (1998) Designing novel RNA binders. Chem. Eur. J., 4, 2091-2098.
49. Hermann,T. (2002) Rational ligand design for RNA: the role of static structure and conformational flexibility in target recognition. Biochimie, 84, 869-875.
50. Daniels,P.J.L., Mallams,A.K., McCombie,S.W., Morton,J.B., Nagabhushan,T.L., Rane,D.F., Reichert,P. and Wright,J.J. (1981) Semisynthetic aminoglycoside antibacterials. Part 11. Solution conformations of semisynthetic and naturally occurring aminoglycoside antibiotics. J. Chem. Soc. Perkin Trans., 1, 2209-2227.
51. Imberty,A. and Perez,S. (2000) Structure, conformation and dynamics of bioactive oligosaccharides: theoretical approaches and experimental validations. Chem. Rev., 100, 4567-4588.
52. Yamana,K., Iwase,R., Furutani,S., Tsuchida,H., Zako,H., Yamaoka,T. and Murakami,A. (1999) 2′-Pyrene modified oligonucleotide provides a highly sensitive fluorescent probe of RNA. Nucleic Acids Res., 27, 2387-2392.
53. Kostenko,E., Dobrikov,M., Pyshnyi,D., Petyuk,V., Komarova,N., Vlassov,V. and Zenkova,M. (2001) 5′-Bis-pyrenylated oligonucleotides displaying excimer fluorescence provide sensitive probes of RNA sequence and structure. Nucleic Acids Res., 29, 3611-3620.